HQL
abrdn Life Sciences Investors
HQL
HQL
55 hedge funds and large institutions have $60.1M invested in abrdn Life Sciences Investors in 2017 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 24 increasing their positions, 13 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
1.73% more ownership
Funds ownership: 12.71% → 14.44% (+1.7%)
4% more capital invested
Capital invested by funds: $57.9M → $60.1M (+$2.17M)
Holders
55
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$2.77M | |
| 2 | +$1.17M | |
| 3 | +$1.07M | |
| 4 |
WAM
Weiss Asset Management
Boston,
Massachusetts
|
+$371K |
| 5 |
DA
Doliver Advisors
Houston,
Texas
|
+$350K |
Top Sellers
| 1 | -$1.2M | |
| 2 | -$1.08M | |
| 3 | -$494K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$466K |
| 5 |
NIM
Needham Investment Management
New York
|
-$208K |